Lundbeck Seattle Biopharmaceuticals
id:
lundbeck-seattle-biopharmaceuticals-297-7635508
title:
Lundbeck Seattle Biopharmaceuticals
text:
Lundbeck Seattle Biopharmaceuticals is a pharmaceutical development company based in Bothell, Washington. Formerly known as Alder Biopharmaceuticals, it specializes in therapeutic monoclonal antibodies. In May 2014, Alder went public. In early 2018, the company made a public stock offering, aiming to raise US$250 million. The company identifies, develops, and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular, and autoimmune and inflammatory disease a
brand slug:
wiki
category slug:
encyclopedia
description:
Pharmaceutical development company
original url:
https://en.wikipedia.org/wiki/Lundbeck_Seattle_Biopharmaceuticals
date created:
date modified:
2023-09-26T22:06:07Z
main entity:
{"identifier":"Q28209837","url":"https://www.wikidata.org/entity/Q28209837"}
image:
fields total:
13
integrity:
14